Evaluating the impact of calibration of patient-reported outcomes measures on results from randomized clinical trials: a simulation study based on Rasch measurement theory
- PMID: 35962310
- PMCID: PMC9375403
- DOI: 10.1186/s12874-022-01680-z
Evaluating the impact of calibration of patient-reported outcomes measures on results from randomized clinical trials: a simulation study based on Rasch measurement theory
Abstract
Background: Meaningfully interpreting patient-reported outcomes (PRO) results from randomized clinical trials requires that the PRO scores obtained in the trial have the same meaning across patients and previous applications of the PRO instrument. Calibration of PRO instruments warrants this property. In the Rasch measurement theory (RMT) framework, calibration is performed by fixing the item parameter estimates when measuring the targeted concept for each individual of the trial. The item parameter estimates used for this purpose are typically obtained from a previous "calibration" study. But imposing this constraint on item parameters, instead of freely estimating them directly in the specific sample of the trial, may hamper the ability to detect a treatment effect. The objective of this simulation study was to explore the potential negative impact of calibration of PRO instruments that were developed using RMT on the comparison of results between treatment groups, using different analysis methods.
Methods: PRO results were simulated following a polytomous Rasch model, for a calibration and a trial sample. Scenarios included varying sample sizes, with instrument of varying number of items and modalities, and varying item parameters distributions. Different treatment effect sizes and distributions of the two patient samples were also explored. Cross-sectional comparison of treatment groups was performed using different methods based on a random effect Rasch model. Calibrated and non-calibrated approaches were compared based on type-I error, power, bias, and variance of the estimates for the difference between groups.
Results: There was no impact of the calibration approach on type-I error, power, bias, and dispersion of the estimates. Among other findings, mistargeting between the PRO instrument and patients from the trial sample (regarding the level of measured concept) resulted in a lower power and higher position bias than appropriate targeting.
Conclusions: Calibration does not compromise the ability to accurately assess a treatment effect using a PRO instrument developed within the RMT paradigm in randomized clinical trials. Thus, given its essential role in producing interpretable results, calibration should always be performed when using a PRO instrument developed using RMT as an endpoint in a randomized clinical trial.
Keywords: Calibration; Clinical trials; Patient-reported outcomes; Rasch measurement theory.
© 2022. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interest.
Figures


Similar articles
-
The FATIGUE-PRO: a new patient-reported outcome instrument to quantify fatigue in patients affected by systemic lupus erythematosus.Rheumatology (Oxford). 2022 Aug 3;61(8):3329-3340. doi: 10.1093/rheumatology/keab920. Rheumatology (Oxford). 2022. PMID: 34897375 Free PMC article.
-
Using classical test theory, item response theory, and Rasch measurement theory to evaluate patient-reported outcome measures: a comparison of worked examples.Value Health. 2015 Jan;18(1):25-34. doi: 10.1016/j.jval.2014.10.005. Value Health. 2015. PMID: 25595231 Clinical Trial.
-
Measurement of Quality of Life in Patients with Mycosis Fungoides/Sézary Syndrome Cutaneous T-Cell Lymphoma: Development of an Electronic Instrument.J Med Internet Res. 2019 Jan 7;21(1):e11302. doi: 10.2196/11302. J Med Internet Res. 2019. PMID: 30617041 Free PMC article.
-
Item banking: a generational change in patient-reported outcome measurement.Optom Vis Sci. 2010 Apr;87(4):285-93. doi: 10.1097/OPX.0b013e3181d408d7. Optom Vis Sci. 2010. PMID: 20142792 Review.
-
A scoping review to create a framework for the steps in developing condition-specific preference-based instruments de novo or from an existing non-preference-based instrument: use of item response theory or Rasch analysis.Health Qual Life Outcomes. 2024 May 14;22(1):38. doi: 10.1186/s12955-024-02253-y. Health Qual Life Outcomes. 2024. PMID: 38745165 Free PMC article.
Cited by
-
Identification of sources of DIF using covariates in patient-reported outcome measures: a simulation study comparing two approaches based on Rasch family models.Front Psychol. 2023 Aug 10;14:1191107. doi: 10.3389/fpsyg.2023.1191107. eCollection 2023. Front Psychol. 2023. PMID: 37637889 Free PMC article.
-
Comparative performance of PROMIS Sleep Disturbance computerized adaptive testing algorithms and static short form in postmenopausal women.J Patient Rep Outcomes. 2025 Feb 17;9(1):18. doi: 10.1186/s41687-025-00849-6. J Patient Rep Outcomes. 2025. PMID: 39961968 Free PMC article.
-
Application of the Rasch measurement model in rehabilitation research and practice: early developments, current practice, and future challenges.Front Rehabil Sci. 2023 Jul 17;4:1208670. doi: 10.3389/fresc.2023.1208670. eCollection 2023. Front Rehabil Sci. 2023. PMID: 37529206 Free PMC article.
References
-
- Health, U.D.o. and H. Services, Guidance for industry-Patient-reported outcome measures: Use in medical product development to support labeling claims. https://www.fda.gov/media/77832/download, 2009. - PMC - PubMed
-
- Fayers P, et al. EORTC QLQ-C30 scoring manual (ed 3). Brussels, Belgium. 2001. EORTC publications.
-
- Fisher Jr WPJM. Invariance and traceability for measures of human, social, and natural capital. Theory Appl. 2009;42(9):1278–1287.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources